Britain has greenlit the country's free healthcare system to use a CRISPR gene-editing therapy for sickle cell anaemia that it is hoped will be a complete cure for the genetic disorder.
Britain has greenlit the country's free healthcare system to use a CRISPR gene-editing therapy for sickle cell anaemia that it is hoped will be a complete cure for the genetic disorder.
www.theguardian.com
UK medicines regulator approves gene therapy for two blood disorders
